Overview
Up to 50% of tuberculosis (TB) survivors have some form of persistent pulmonary dysfunction despite microbiologic cure.
Furthermore, treated TB patients appear to contribute substantially to the growing burden of Chronic lung diseases.
Faculty
Dr Raja Dhar
MBBS (Cal), MD (Respiratory Medicine), MRCP (UK) MSc (Evidence Based Medicine, UK) CCT (Respiratory and General Medicine UK), FCCP (USA), Diploma in Palliative Care (Newcastle University) Certificate in Education (Deeside University)
Director & HoD Pulmonology, Fortis Hospital. Director, Research & Education, National Allergy Asthma Bronchitis Institute, Kolkata, IndiaResources
External Resources
Also Read
